SCHEMBL20402153

SCHEMBL20402153

c1ccc(-c2ccc3c(c2)[nH]c2c3ccc3c2ccc2c4ccc(-c5ccccc5)cc4sc23)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIMK1 P53667 2/20 0.45
TNKS2 Q9H2K2 2/20 0.44
FEN1 P39748 1/20 0.41
GSK3B P49841 1/20 0.40
JAK2 O60674 1/20 0.40
CDK4 P11802 1/20 0.39
CCND1 P24385 1/20 0.39
TNKS O95271 1/20 0.38
MEN1 O00255 2/20 0.38
MAPT P10636 2/20 0.38
KMT2A Q03164 2/20 0.38
RAB9A P51151 1/20 0.38
GPR17 Q13304 1/20 0.37
KIF11 P52732 1/20 0.37
PTGES O14684 2/20 0.36
KDM4E B2RXH2 1/20 0.36
GAA P10253 1/20 0.36
PIK3CA P42336 1/20 0.36
PI4KA P42356 1/20 0.36
PI4KB Q9UBF8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24834377 0.87 MEN1 (0.55) LIMK1TNKS2FEN1GSK3BJAK2
SCHEMBL23609820 0.87 MEN1 (0.55) LIMK1TNKS2CDK4CCND1TNKS
SCHEMBL24833500 0.87 MEN1 (0.55) LIMK1TNKS2FEN1GSK3BJAK2
SCHEMBL22031877 0.85 LIMK1 (0.55) LIMK1TNKS2JAK2TNKSMAPT
SCHEMBL24833378 0.84 MEN1 (0.53) LIMK1TNKS2FEN1GSK3BJAK2
SCHEMBL20402154 0.82 GPR17 (0.42) GSK3BGPR17PTGESTDO2CHEK1
SCHEMBL25442153 0.82 LIMK1 (0.55) LIMK1TNKS2JAK2TNKSMAPT
SCHEMBL19109265 0.80 LIMK1 (0.51) LIMK1TNKS2TNKSMAPTRAB9A
SCHEMBL15894714 0.79 ALOX5 (0.46) LIMK1TNKS2CDK4CCND1TNKS
SCHEMBL24833490 0.79 MEN1 (0.50) TNKS2FEN1GSK3BCDK4CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10032993-B2 Aromatic heterocyclic compound, manufacturing method thereof, organic semiconductor material, and organic semiconductor device NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) 2018-07-24 US disclosed
US-10032993-B2 Aromatic heterocyclic compound, manufacturing method thereof, organic semiconductor material, and organic semiconductor device NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) 2018-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10032993-B2 Aromatic heterocyclic compound, manufacturing method thereof, organic semiconductor material, and organic semiconductor device PAH, TYR, SLCO2A1 LIMK1 1798/4885TNKS2 4087/4885FEN1 3240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.